Atlas Trials

A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients

Clinical trial NCT00254436 · TERMINATED

Trial details

NCT number
NCT00254436
Sponsor
M.D. Anderson Cancer Center
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Gastrointestinal CancerRectal Cancer
Start date
2001-10-31
Primary completion
2004-06-29
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.